Is it safe to continue/re-challenge oxaliplatin in patients with oxaliplatin-induced hepatic sinusoidal injury and splenomegaly?

Typically, if there is documented hepatic injury, I will not revisit oxaliplatin as continued therapy will result in continued injury that may limit future therapeutic options. Given that many GI oncology patients will receive multiple agents that are metabolized through the liver and/or have hepati...